A Study of LY2216684 and Warfarin in Healthy Subjects

NCT01263119 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Warfarin
DRUG: LY2216684

Sponsor

Eli Lilly and Company